Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PTC Therapeutics
Biotech
PTC bounces back with positive data on FA prospect vatiquinone
Several months after forging a path forward for its Friedreich ataxia drug vatiquinone, PTC Therapeutics is back with some much-needed good news.
Fraiser Kansteiner
Oct 8, 2024 9:34am
After pair of failures, PTC finds path for Friedreich ataxia med
Mar 1, 2024 9:20am
FDA demands data on 2 PTC candidates, delaying filing
Oct 27, 2023 7:30am
PTC deepens layoffs as DMD drug faces loss of EU authorization
Sep 29, 2023 8:51am
PTC suffers 2nd vatiquinone failure in quick succession
Jun 30, 2023 6:25am
PTC plots path to rare disease approval despite phase 3 fail
May 24, 2023 6:20am
